Почетна › Steatotna bolest jetre › Arizona
Kliničke studije za Steatotna bolest jetre u državi Arizona
14 studija za Steatotna bolest jetre traži učesnike na lokacijama u državi Arizona.
Gradovi u državi Arizona
Zvanični tekst studije (na engleskom)
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Chandler
- GSK Investigational Site, Phoenix
- GSK Investigational Site, Tucson
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 13. 11. 2026. · NCT06613698A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Chandler
- Akero Clinical Study Site, Peoria
- Akero Clinical Study Site, Scottsdale
- и још 4
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT06528314Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- Adobe Clinical Research, Tucson
- The Institute for Liver Health II LLC dba Arizona Liver Health, Tucson
- Del Sol Research Management, LLC, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07631637A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arizona Liver Health, Chandler
- Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, LLC, Tucson
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 11. 2026. · NCT07288138A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Mesa
- GSK Investigational Site, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT06920043Early Tracking of Childhood Health Determinants (ETCHED) Study
- NIDDK, Phoenix, Phoenix
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
1 Day – 99 Years · Оба пола · Ажурирано 2. 11. 2026. · NCT03481829A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Peoria
- 89bio Clinical Study Site, Phoenix
- и још 4
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 23. 10. 2026. · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Glendale
- 89bio Clinical Study Site, Sun City
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 80 · Оба пола · Ажурирано 23. 10. 2026. · NCT06318169A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
- Spectrum Research Institute, Gilbert
- The Institute for Liver Health II dba Arizona Liver Health - Peoria, Peoria
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07165028A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Arizona Liver Health - Tucson, Tucson
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 29. 9. 2026. · NCT07527910Fibrosis Lessens After Metabolic Surgery
- Banner Health Center, Phoenix
Тражи се учесникФаза 4Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 31. 7. 2026. · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Tucson
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 7. 2026. · NCT07221227Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Arizona Liver Health, Chandler
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 5. 2026. · NCT04054310Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Mayo Clinic in Arizona, Scottsdale
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 30 до 70 · Оба пола · Ажурирано 28. 1. 2026. · NCT04232566Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.